MM
Memento Medicines, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$38Msold at filing
Total offering$93M$55M still open
Investors in the raise7count reported to the SEC
FiledJun 16, 2026first sale Jun 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Zach Basil ScheinerDirector
William Daley BonificioExecutive Officer, Promoter
Megan Basil KrenchDirector
Stephen Basil ThomasExecutive Officer, Promoter
Dmitrij Basil HristodorovDirector
Naveen Manu DaryaniExecutive Officer, Director, Promoter
Vishal Basil KapoorDirector
Executive officers, directors and promoters as listed on the Form D.